We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLNT
2876
Fluent
FLNT
$120M
$104K ﹤0.01%
8,336
-893
-10% -$9.11K
VRCA icon
2877
Verrica Pharmaceuticals
VRCA
$87.3M
$104K ﹤0.01%
1,277
-58
-4% -$4.78K
CRD.A icon
2878
Crawford & Co Class A
CRD.A
$669M
$103K ﹤0.01%
13,581
-1,486
-10% -$11.3K
CURV icon
2879
Torrid Holdings
CURV
$260M
$103K ﹤0.01%
16,963
+6,661
+65% +$56.7K
GTYH
2880
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$102K ﹤0.01%
31,676
-3,924
-11% -$18.2K
VIA
2881
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$101K ﹤0.01%
2,462
-114
-4% -$6.05K
TLRY icon
2882
Tilray
TLRY
$622M
$100K ﹤0.01%
1,284
– –
TAST
2883
DELISTED
Carrols Restaurant Group, Inc.
TAST
$100K ﹤0.01%
44,035
-5,782
-12% -$14.9K
SBDS
2884
DELISTED
Solo Brands Inc
SBDS
$100K ﹤0.01%
+292
New +$129K
HOWL icon
2885
Werewolf Therapeutics
HOWL
$19.3M
$99K ﹤0.01%
22,550
+3,245
+17% +$22.7K
VOR icon
2886
Vor Biopharma
VOR
$1.28B
$99K ﹤0.01%
817
-100
-11% -$17K
HMTV
2887
DELISTED
Hemisphere Media Group, Inc.
HMTV
$99K ﹤0.01%
21,558
-1,918
-8% -$11.5K
EVLO
2888
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$98K ﹤0.01%
1,441
+244
+20% +$20.3K
IBIO icon
2889
iBio
IBIO
$70M
$97K ﹤0.01%
455
-55
-11% -$11.5K
INNV icon
2890
InnovAge Holding
INNV
$1.52B
$97K ﹤0.01%
15,157
+1,774
+13% +$8.96K
TCRR
2891
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$97K ﹤0.01%
35,135
-2,932
-8% -$9.22K
COCO icon
2892
Vita Coco
COCO
$3.6B
$96K ﹤0.01%
+10,660
New +$111K
OMGA
2893
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$96K ﹤0.01%
+15,329
New +$156K
HLTH
2894
DELISTED
Cue Health Inc. Common Stock
HLTH
$96K ﹤0.01%
14,816
+4,795
+48% +$43.4K
BCEL
2895
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$96K ﹤0.01%
30,359
-4,063
-12% -$9.86K
FBIO icon
2896
Fortress Biotech
FBIO
$88.7M
$94K ﹤0.01%
4,607
+586
+15% +$16K
KALA icon
2897
KALA BIO
KALA
$14.5M
$94K ﹤0.01%
27
– –
NMTR
2898
DELISTED
9 Meters Biopharma
NMTR
$93K ﹤0.01%
7,733
+172
+2% +$2.35K
INFI
2899
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$92K ﹤0.01%
80,564
+5,742
+8% +$6.86K
PSEC icon
2900
Prospect Capital
PSEC
$1.17B
$91K ﹤0.01%
11,045
-2,510
-19% -$20.9K
114 115
116
117 118

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.